113 related articles for article (PubMed ID: 2903461)
1. Effects of systemic and intracerebroventricular cysteamine on dexamethasone-induced suppression of corticosterone levels in the rat.
Radke JM; Vincent SR
Neuroendocrinology; 1988 Sep; 48(3):258-63. PubMed ID: 2903461
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin in the hippocampus mediates dexamethasone-induced suppression of corticosterone secretion in the rat.
Ferrara C; Cocchi D; Müller EE
Neuroendocrinology; 1991 Apr; 53(4):428-31. PubMed ID: 1675439
[TBL] [Abstract][Full Text] [Related]
3. Recovery of the rat hypothalamic-pituitary-adrenal axis after discontinuation of prolonged treatment with the synthetic glucocorticoid agonist dexamethasone.
Calogero AE; Kamilaris TC; Johnson EO; Tartaglia ME; Chrousos G
Endocrinology; 1990 Oct; 127(4):1574-9. PubMed ID: 2169393
[TBL] [Abstract][Full Text] [Related]
4. Effects of cysteamine administration on somatostatin biosynthesis and levels in rat hypothalamus.
Kwok RP; Cameron JL; Faller DV; Fernstrom JD
Endocrinology; 1992 Dec; 131(6):2999-3009. PubMed ID: 1359964
[TBL] [Abstract][Full Text] [Related]
5. Effects of ovariectomy on dexamethasone suppression of the adrenal axis in adult rats.
Ramaley JA
Neuroendocrinology; 1976; 20(3):260-9. PubMed ID: 958597
[TBL] [Abstract][Full Text] [Related]
6. Role of somatostatin in the regulation of vasopressin secretion.
Brown MR; Mortrud M; Crum R; Sawchenko P
Brain Res; 1988 Jun; 452(1-2):212-8. PubMed ID: 2900049
[TBL] [Abstract][Full Text] [Related]
7. Effects of cysteamine administration on the in vivo incorporation of [35S]cysteine into somatostatin-14, somatostatin-28, arginine vasopressin, and oxytocin in rat hypothalamus.
Cameron JL; Fernstrom JD
Endocrinology; 1986 Sep; 119(3):1292-7. PubMed ID: 2874017
[TBL] [Abstract][Full Text] [Related]
8. Effects of cysteamine on pro-somatostatin related peptides.
Bakhit C; Benoit R; Bloom FE
Regul Pept; 1983 May; 6(2):169-77. PubMed ID: 6192467
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid modulation of atrial natriuretic peptide, oxytocin, vasopressin and Fos expression in response to osmotic, angiotensinergic and cholinergic stimulation.
Lauand F; Ruginsk SG; Rodrigues HL; Reis WL; de Castro M; Elias LL; Antunes-Rodrigues J
Neuroscience; 2007 Jun; 147(1):247-57. PubMed ID: 17524563
[TBL] [Abstract][Full Text] [Related]
10. Antiglucocorticoid RU 38486 attenuates retention of a behaviour and disinhibits the hypothalamic-pituitary adrenal axis at different brain sites.
De Kloet ER; De Kock S; Schild V; Veldhuis HD
Neuroendocrinology; 1988 Feb; 47(2):109-15. PubMed ID: 3344063
[TBL] [Abstract][Full Text] [Related]
11. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
[TBL] [Abstract][Full Text] [Related]
12. Stimulatory effect of interleukin-1 on adrenocorticotropin secretion in the rat: is it modulated by prostaglandins?
Rivier C; Vale W
Endocrinology; 1991 Jul; 129(1):384-8. PubMed ID: 1647302
[TBL] [Abstract][Full Text] [Related]
13. Degree of inhibition of ACTH release by glucocorticoids in adrenalectomized rats.
Sakakura M; Yoshioka M; Kobayashi M; Takebe K
Neuroendocrinology; 1981 Jan; 32(1):38-41. PubMed ID: 6258095
[TBL] [Abstract][Full Text] [Related]
14. Hypothalamic and suprahypothalamic effects of prolonged treatment with dexamethasone in the rat.
Calogero AE; Liapi C; Chrousos GP
J Endocrinol Invest; 1991 Apr; 14(4):277-86. PubMed ID: 1650804
[TBL] [Abstract][Full Text] [Related]
15. Effect of chronic m-CPP on locomotion, hypophagia, plasma corticosterone and 5-HT2C receptor levels in the rat.
Fone KC; Austin RH; Topham IA; Kennett GA; Punhani T
Br J Pharmacol; 1998 Apr; 123(8):1707-15. PubMed ID: 9605579
[TBL] [Abstract][Full Text] [Related]
16. The hypothalamic mechanisms of the hypophysiotropic action of ghrelin.
Wren AM; Small CJ; Fribbens CV; Neary NM; Ward HL; Seal LJ; Ghatei MA; Bloom SR
Neuroendocrinology; 2002 Nov; 76(5):316-24. PubMed ID: 12457042
[TBL] [Abstract][Full Text] [Related]
17. A critical evaluation of cysteamine as a tool to deplete somatostatin in the rat central nervous system.
Cook LL; Bissette G; Dole K; Nemeroff CB
Endocrinology; 1989 Feb; 124(2):855-61. PubMed ID: 2563244
[TBL] [Abstract][Full Text] [Related]
18. Concomitant infusion of ovine corticotropin-releasing hormone does not prevent suppression of the hypothalamus-pituitary-adrenal axis by dexamethasone in male rats.
Huang TS
J Endocrinol Invest; 1997; 20(7):393-6. PubMed ID: 9309537
[TBL] [Abstract][Full Text] [Related]
19. The site of inhibitory action of a natural (corticosterone) and synthetic steroid (dexamethasone) in the hypothalamic-pituitary-adrenal axis.
Sakakura M; Yoshioka M; Kobayashi M; Takebe K
Neuroendocrinology; 1981 Mar; 32(3):174-8. PubMed ID: 6261179
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-induced somatostatin release from perifused rat hypothalamus: calcium dependency and effect of cysteamine treatment.
Shimatsu A; Kato Y; Matsushita N; Ohta H; Kabayama Y; Imura H
Neurosci Lett; 1983 Jun; 37(3):285-9. PubMed ID: 6136940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
